NONQUALIFIED STOCK OPTION AGREEMENT AQUAMED TECHNOLOGIES, INC.Nonqualified Stock Option Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus
INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus
RESTRICTED STOCK AWARD AGREEMENT AQUAMED TECHNOLOGIES, INC.Restricted Stock Award Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus
VOID AFTER 5:00 P.M. ON NOVEMBER 1, 2023 TO PHARMACEUTICALS LLC WARRANT TO PURCHASE UNITSWarrant Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS IS TO CERTIFY THAT, for value received, Bernard Sucher, an individual residing at 715 Sevilla Avenue, Coral Gables, Florida 33134-5627 (the “Warrantholder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from TO Pharmaceuticals LLC, a Delaware limited liability (the “Company”), up to 5,594 Class A Units (the “Warrant Units”) of the Company (“Units”), at an exercise price equal to $45.32 per Unit (the “Exercise Price”) at the times and in the manner set forth below.
LICENSE AGREEMENTLicense Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus • New York
This License Agreement (this “Agreement”), dated as of April 13, 2017 (the “Effective Date”), is by and between Tikun Olam Ltd., an Israeli corporation, registration number 514263771 (“Licensor”) and TO Pharmaceuticals USA LLC, a Delaware limited liability company (“Licensee”). Licensor and Licensee shall each be individually referred to as a “Party” and collectively as the “Parties”.
VOID AFTER 5:00 P.M. ON MARCH 9, 2023 TO PHARMACEUTICALS LLC WARRANT TO PURCHASE UNITSWarrant Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS IS TO CERTIFY THAT, for value received, Sidney Taubenfeld, an individual residing at 247 West 87th Street, Apt. 7G, New York, New York 10024 (the “Warrantholder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from TO PHARMACEUTICALS LLC, a Delaware limited liability (the “Company”), up to 500 units (the “Warrant Units”) of the membership interests of the Company (“Units”), at an exercise price equal to $700 per Unit (the “Exercise Price”) at the times and in the manner set forth below.
EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus • Delaware
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of March 9, 2016 is by and between TO Pharmaceuticals LLC, a Delaware limited liability company (the “Company”) and Sidney Taubenfeld, an individual residing at 247 West 87th Street, Apt. 7G, New York, New York 10024 (the “Employee”).
TO Pharmaceuticals LLCManagement Consulting Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus
We are very pleased to offer you the position of Interim Chief Executive Officer (“CEO”) of TO Pharmaceuticals LLC, a Delaware limited liability company (the “Company”), effective as of October 1, 2018. This offer of is conditioned on your satisfactory completion of certain requirements, as more fully explained in this letter. Your role as CEO will be subject to the terms and conditions set forth in this letter, which supersede anything said or communicated to you during any discussions or correspondence about your employment with the Company or its affiliates. Your firm, Sutherland Paige and Associates, Inc. D/B/A Katan Associates, International (“Katan”), will be engaged as an consultant and independent contractor to the Company to provide your services on an interim basis until you and the Company enter into a definitive employment agreement (the “Employment Agreement”).
BILL OF SALE AND ASSIGNMENT AND ASSUMPTION AGREEMENTBill of Sale and Assignment and Assumption Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus • Delaware
This BILL OF SALE AND ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”) is delivered as of [●], 20__, by and among Alliqua BioMedical, Inc., a Delaware corporation (“Alliqua”), and AquaMed Technologies, Inc., a Delaware corporation (“AquaMed”). Alliqua and AquaMed are each individually referred to herein as a “Party”, and collectively referred to herein as the “Parties”.
MASTER INTERCOMPANY SERVICES AGREEMENTMaster Intercompany Services Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus • New York
This MASTER INTERCOMPANY SERVICES AGREEMENT (this “Agreement”) is made and entered into as of January 1, 2018, by and among certain subsidiaries of T.O. GLOBAL LLC, a New York Limited Liability Company (“Parent”) providing services (as set forth in Schedule B hereto, collectively, the “Service Providers”) and certain subsidiaries of Parent receiving such services (as set forth in Schedule B hereto, collectively, the “Service Recipients”).
